Immunic (IMUX) Depreciation and Depletion (2018 - 2024)

Immunic's (IMUX) quarterly Depreciation and Depletion came in at $42000.0 in Q3 2024, up 23.53% year-on-year from $34000.0 in Q4 2023, and up 35.48% quarter-over-quarter from $31000.0 in Q2 2024.

Immunic (IMUX) Depreciation and Depletion (2018 - 2024) Analysis & Trends

Immunic has disclosed Depreciation and Depletion across 7 years of filings, most recently posting $42000.0 for Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 1,395.22
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -1,330.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 Immunic 384.84 Mn 198.21 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 42,000.00
Sep 30, 2024 42,000.00
Jun 30, 2024 31,000.00
Jun 30, 2024 31,000.00
Mar 31, 2024 26,000.00
Mar 31, 2024 26,000.00
Sep 30, 2023 34,000.00
Sep 30, 2023 34,000.00
Jun 30, 2023 22,000.00
Jun 30, 2023 22,000.00
Mar 31, 2023 32,000.00
Mar 31, 2023 32,000.00
Sep 30, 2022 17,000.00
Sep 30, 2022 17,000.00
Jun 30, 2022 20,000.00
Jun 30, 2022 20,000.00
Mar 31, 2022 32,000.00
Mar 31, 2022 32,000.00
Sep 30, 2021 17,000.00
Sep 30, 2021 17,000.00